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Abstract
Minimally invasive facial rejuvenation procedures reached an all-time high in the 2016. This reveals a growing interest in a
smoother, younger, and tighter look accessible using the esthetic medicine tools like botulinum toxin and dermal filler injections,
laser, and microdermabrasion. Forty-five patients from 35 to 52 years old (medium age 43.8), 38 women and 7 men underwent 5
sessions of Fraxel laser, 1 session of very low G prime HA, and Microbotox injection treatments from January 2016 and January
2017, were included in this study. In this study, we demonstrated that the usage of three treatments together, like mBTX, Volite,
and Fractional laser, have a better result despite every single technique alone. The clinical result showed 98% (44 patients, 6
males, 38 females) of the patients had a smoother skin surface, brighter, more hydrated, and elastic skin; 68% of our patients (31
patients, 5 males, 26 females) showed less skin defects and staining as well as less small wrinkles, thanks to Fraxel laser
treatment; 98% (44 patients, 6 males, 38 females) showed tighter skin with less sebaceous gland secretion. The aim of this study
was to demonstrate that the combination of three techniques acts better and faster than single treatment to contrast facial aging and
to improve skin texture and quality.
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Introduction
According to the ASAPS statistics, minimally invasive facial
rejuvenation procedures reached an all-time high in the 2016.
This reveals a growing interest in a smoother, younger, and
tighter look using non-surgical tools like Botox, Dermal Filler
injections, and laser. Botox injections increased by 8% with
millions of procedures performed and nowadays, esthetic
medicine is considered an excellent alternative to plastic
surgery, when patients are not looking for a surgical treatment
[1–3].
Facial aging alters skin in several ways [4]: collagen pro-
duction slows, loss of ability to retain moisture, reduction of
fat cells, elastin production decreases, less turnover of new
skin cells, etc. All these factors contribute to alter skin quality
and texture and, according to the literature, skin aging is di-
rectly linked particularly with those last two features, in par-
ticular in sun-exposed skin area.
It is possible to consider two different kinds of mechanism
of aging: intrinsic and extrinsic. The first one is linked to
genetics while the extrinsic factors are exposure to UV radia-
tion, pollution, and cigarette smoking, practically everything
that can accelerate the intrinsic skin aging; therefore, it is
possible to consider facial aging like a multifactorial process.
As we age, some facial muscles tend to be hyperactive [5]
with the depressors overpowering the elevators. This can be
observed in the lateral brows and on the mouth angles. The
forehead lines become apparent as a result of the hyperactive
frontalis and create dynamic wrinkles. When we are young,
our skin springs back due to its elasticity, but as we get older,
the dynamic wrinkles will eventually end up in static wrinkles.
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One non-surgical tool to contrast the skin aging and im-
prove skin quality and texture is the combination of
microbotulinum toxin A, hyaluronic acid (HA) fillers, and
laser.
Microbotulinum toxin A is a technique that is becoming
more and more popular. Treatment is relatively easy to per-
form and it consists in a series of injections (micro-droplets) of
diluted onabotulinumtoxinA at 0.8- to 1.0-cm intervals into
the dermis or the interface between the dermis and the super-
ficial layer of facial muscles. The intent is not to completely
paralyze the underlying facial muscles but only to weaken the
superficial fibers that are inserted into the undersurface of the
skin, which are responsible for the fine lines and wrinkles on
the face and neck. Moreover, Microbotox injections decrease
sweat and sebaceous gland activity to improve skin texture
and sheen and to target the superficial layer of muscles that
find attachment to the undersurface of the dermis causing
visible rhytides. It works very well for stretching wrinkles
and for recovering the natural skin texture and quality.
HA fillers are substances injected into the face in order to
fill volume deficits and improve surface contours. They have
rapidly gained remarkable acceptance over the past decade as
a method of reliably enhancing the topographic features of the
human face. Treatment can be performed deep or intradermal-
ly and HA can be used to fill superficial cutaneous depressions
such as fine lines and for additional improvement of skin
quality attributes such as hydration and elasticity.
Laser, in particular Fraxel laser, works creating a series of
tiny microthermal zone deep in the skin which the skin repairs
by pushing out the Bold and damaged^ cells, replacing them
with new skin cells. In other words, laser triggers the body’s
natural healing process accelerating the production of collagen
and new healthy skin [6].
The aim of this study is to demonstrate that the combina-
tion of that three techniques is better than single treatment and
their association can boost the improvement of the skin texture
and quality to rejuvenate patients’ face.
Materials and methods
Forty-five patients from 35 to 52 years old (medium age 43.8),
38 women and 7 men underwent 5 sessions of Fraxel laser, 1
session of very low G prime HA, and Microbotox injection
treatments from January 2016 and January 2017, were includ-
ed in this study.
All of the patients were Caucasian, with no history of sur-
gical or non-surgical procedures to improve skin quality (in
particular semi-permanent or permanent filler and Botox
users), without facial scars and facial tattoos. Patients with
history of endocrinologic, cardiologic, dermatologic, and on-
cologic illnesses were excluded. Moreover, people who were
ch ron i c a l l y t ak ing d rugs l i k e co r t i c o s t e ro id s ,
immunomodulators, and other medicines that may have inter-
fered with skin response were also excluded from the study.
Before starting each treatment session, we did a complete
assessment of the patient in order to give the best result possible.
We considered some different parameters: horizontal or vertical
facial asymmetries, proportion and shape of the face (forehead
height, distance between the eyebrows), tics or spastic abnormal-
ities related to facial muscles, any skin discolorations, eyelid
condition (upper ptosis, skin laxity of the lower face, chronic
edema), brow ptosis and potential hyper-compensation of the
frontal muscle, contraction of the orbicularis muscle (for crow’s
feet), smile dynamics (muscle hyperactivity, dental exposure, and
degree of occlusion), hyperactivity of the mental muscle (orange
peel chin), and platysma bands.
Evaluations of specific parameters must be carried out
when the patient is seated, in natural head position, both at
rest and in facial dynamic movements. A change of position of
the subject, such as flexion or extension of the head, can cause
major changes in the whole image and can lead, therefore, to a
different assessment of the result.
It is generally accepted that all esthetic procedures must be
photographically documented. We acquired a photographic
record before and after the treatment, and at any subsequent
step, obtaining the consent for the processing of personal data,
privacy, and patient waive.
Microbotox, HA fillers, and Fraxel laser were performed in
different sessions. Firstly, patients were treated with five ses-
sions of Fraxel laser, one session every 3 weeks; then, we used
to treat patients with Microbotox (one session) and lastly, we
injected very low G HA filler (one session).
All the patients received a full facial treatment including neck.
Treatment sessions
Microbotox
Onabotulinumtoxin A (Vistabex®, Allergan Inc., Irvine, CA)
was used. For glabellar, crow’s-feet, forehead, and infraorbital
regions, the concentration of Microbotox used is 20 units in
1 mL of solution [7].
Vistabex was resuspended at the recommended dilution of
1.25 mL. The Microbotox solution is mixed in the syringe by
adding lidocaine (0.5 ml of the recommended dilution with
0.5% lidocaine solution equivalent to a final solution of 20 U
of toxin). Each 1 mL syringe ofMicrobotox solution is used to
deliver 80–100 injections (0.01 ml approx.). The upper face
and periorbital area usually require 1 mL per side. The injec-
tions are delivered intradermally using a 30- or 32-G needle
raising a tiny blanched weal at each point.
Care must be taken to just penetrate the needle into the skin
as superficially as possible. A resistance should be felt on
pressing the plunger, and a small raised, blanched bleb in the
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skin should be seen. This indicates good depth of injection. If
the solution is easily injected, the needle has probably been
inserted too deeply and is subdermal or intramuscular.
The initial prick may be painful, but within 1 or 2 s, the
injection point becomes anesthetized and no longer bothers
the patients as the rest of the injections are completed in re-
maining areas. At the end of the procedure, patients do not
experience any pain. The duration of improvement after a
session of Microbotox typically lasts for 3–4 months and in
some cases up to 6 months.
We used Juvapen® (Juvaplus SA Neuchâtel Switzerland) to
inject Botox; it is a device that allows to use every time the
same dose of toxin with less variability than manual injection.
Patients experienced less pain, less edema, and a shorter treat-
ment time. On the other hand, this device allows to save a lot of
toxin (approx. 20%). Juvapen has 6 preset doses from 0.0125 to
0.1 ml [8].
Fraxel laser
Fractional photothermolysis is a non-ablative resurfacing laser
technique, in which the laser creates microthermal zones of
Binjury^ randomly integrated onto the skin. Within these
areas, localized epidermal necrosis occurs alongside collagen
denaturation, followed by expulsion of the necrotic debris and
neocollagenesis. In the non-ablated areas, these islands of nor-
mal skin serve as an epithelial bridgewith factors that facilitate
a quicker healing process [9].
We used 1550-nm (Fraxel SR1500 RE:Store; Solta
Medical, Hayward, CA).
Energy was set in accordance with Classification and
Features of Skin Types as described by Fitzpatrick (Table 1).
Topical anesthetic (lidocaine hydrochloride, 7%, and tetra-
caine hydrochloride, 7%) was applied to the treatment area for
45 min prior to treatment [10]. Proper laser safety precautions
were instituted. All subjects were discharged with a nonchemical
sunscreen as well as instructions for antiviral medication for
those who had a history of facial and/or labial herpes. Each
session last about 30 min. All the face and neck areas were
treated.
Very low G prime HA filler
Several classes of facial fillers are available. The safest and
most widely accepted filler is crosslinked hyaluronic acid
(HA). HA is considered a volumizer in that its effect depends
largely on the bulk effect of the injected product rather than
inflammation and the stimulation of collagen production. It is
accepted that the HA molecular weight is the most important
feature to predict its function. In this study, our goal is to
improve skin quality and texture. Juvederm® Volite
(Allergan Inc., Irvine, CA) has very low GHA filler (Table 2).
We treated all the patients in one session only. The mini-
mum quantity was 2 ml of Volite and the maximum was 4 ml
(average 2.5 ml per patient).
When injections were performed, we stretched the skin to
increase tension using an oblique injection angle; the product
was injected intradermally and very slowly with microaliquot
droplets. We stopped the injection before retruding the needle
backwards.
Usually, we started the procedure in the lateral malar region
because this allowed calibration of injection technique to in-
dividual patient needs and microarchitecture in a lower visi-
bility area; patient experienced less pain in this area and if a
lump is induced; it was less visible [11].
We treated all the face and neck depressions.
Results
We followed up our patients for 12 months with clinical
checks at 1, 3, and 6 months. We gave our patients a clinical
questionnaire (from 1 to 10) asking them to rate the satisfac-
tion level which in 100% of our patients got an average of 7.8.
The clinical result showed the following data:
1) In 98% (44 patients, 6 males, 38 females) of our patient
population, a smoother skin surface, brighter, and more
hydrated and elastic skin;
2) Sixty-eight percent of our patients (31 patients, 5 males,
26 females) showed less skin defects and staining as well
as less small wrinkles, thanks to Fraxel laser treatment;
Table 1 FitzPatrick skin type table
FitzPatrick
skin type
Skin tone Tanning history
I Ivory Never tan/always burns
II Beige Find it difficult to tan/usually burns
III Light brown Tans gradually/mild burns sometimes
IV Medium brown Easily tans/burns rarely
V Dark brown Easily tans/very rarely burns
VI Very dark brown Tans very easily/never burns
Table 2 Formulation of Juverderm® Volite
Juvederm® Volite
HA (mg/ml) 12
HA molecular weight (higher/lower) Majority lower molecular weight
Cross-linking technology Vycross
Lidocaine hydrochloride (%w/w gel) 0.3
Syringe type COC
Syringe fill (ml) 1.0
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3) Ninety-eight percent (44 patients, 6 males, 38 females)
showed tighter skin with less sebaceous gland secretion.
The complication rate was 21%. Among these, the more
frequent were as follows: 12% hematoma (Volite and mBTX),
6% nodules formation (Volite), 25% pain during laser, and
17% during Volite injection. No side effects were noted with
the mBTX injections; in particular, there were no cases of
facial asymmetry.
Clinical case 1: Before and after
Clinical case 2: Before and after
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Discussion
Esthetic medicine aims to rejuvenate skin and to restore facial
balance. One of the most important aspects for facial balance
is the quality of skin and its texture and facial aging is directly
related with that.
Skin aging is a complex biological process influenced by
combination of endogenous or intrinsic (genetics, cellular me-
tabolism, hormone, and metabolic processes) and exogenous
or extrinsic (chronic light exposure, pollution, ionizing radia-
tion, chemicals, toxins) factors [4, 7]. These factors lead to-
gether to cumulative structural and physiological alterations
and progressive changes in each skin layer as well as changes
in skin appearance, especially, on the sun-exposed skin areas.
In contrast to thin and atrophic, finely wrinkled and dry intrin-
sically aged skin, premature photoaged skin typically shows a
thickened epidermis, mottled discoloration, deep wrinkles,
laxity, dullness, and roughness. Gradual loss of skin elasticity
leads to the phenomenon of sagging. Slowing of the epidermal
turnover rate and cell cycle lengthening coincides with a
slower wound healing and less effective desquamation in
older adults. This fact is important when esthetic procedures
are scheduled. On the other side, many of these features are
targets to product application or procedures to accelerate the
cell cycle, in the belief that a faster turnover rate will yield
improvement in skin appearance and will speed wound
healing. A marked loss of fibrillin-positive structures as well
as a reduced content of collagen type VII (Col-7) may con-
tribute to wrinkles by weakening the bond between dermis
and epidermis of extrinsically age skin. Sun-exposed aged
skin is characterized by the solar elastosis. The sparse distri-
bution and decrease in collagen content in photoaged skin can
be due to increased collagen degradation by various matrix
metalloproteinases, serine, and other proteases irrespective of
the same collagen production [4].
Three primary structural components of the dermis, colla-
gen, elastin, and GAGs have been the subjects of the majority
of anti-aging research and efforts for esthetic anti-aging strat-
egies pertaining to the skin from Banti-wrinkle creams^ to
various filling agents.
Presentation of aging of the entire face is associated with
the gravity impact, muscles action, loss of volume,
diminishing and redistribution of superficial and deep fat,
and loss of bony skeleton support what all together lead to
the face sagging and changes in shape and contour. Regardless
of the fact that aging is a biological inevitable process and not
a pathological condition, it can be correlated with various skin
and body pathologies, including degenerative disorders and
benign and malignant neoplasms.
The mainspring of any skin anti-aging therapy is to achieve
a healthy, smooth, blemish-free, translucent, and resilient skin.
In clinical practice, Bto look better^ does not mean to Blook
younger.^ That is why it is so important to understand
patients’ wishes and to orientate them to the treatment modal-
ity that will give the most satisfying results whereas knowing
all available treatment techniques. The age, previous proce-
dures or surgery, general health status, type of the skin, style of
life, and many other factors should be taken into consideration
before choosing the strategy for the individual case. The de-
sired therapeutic anti-aging effect of the skin is a continuous,
step-by step process, which combines various methods of the
skin bio-revitalization and rejuvenation, augmentation, and
restoration of each skin layer individually and in the light of
many other factors from a style of the life to the immune,
genetic, emotional, and health status in general. What we did
in this study was trying to prevent or treat skin aging in three
different ways, all together, to improve skin quality and tex-
ture because there are many factors that lead together [7].
Microbotox acts weakening the superficial fibers that are
inserted into the undersurface of the skin, in this way
diminishing wrinkles. In addition, the smooth lustrous appear-
ance of the forehead skin due to decreased sweat and seba-
ceous gland activity was an additional effect that leads to
improved skin quality and texture [5].
MBTX has a standardized injection and dilution technique.
It is more convenient to use Botox from a bottle of 100 units
that has been reconstituted with 2.5 mL of saline (standard
dilution).
Further dilution, adding lidocaine like it said before, to
the appropriate Microbotox concentration is done in the
syringe itself. This allows the bottle of standard Botox to
be retained should it be needed in a more concentrated
form for masseteric injections or when needed to admin-
ister more concentrated Botox to key points of the face.
This decreases the likelihood of delivering a droplet vol-
ume that is too large, which could diffuse out of the target
zone and create unintended effects.
For which concern lower face and neck treatment, accord-
ing to Wu, the most important target is the platysma muscle.
When it is treated (usually with 200/250 microdoplets), clin-
ically the cervico-mental angle and jawline appear sharper and
the jowls appear lifted as the platysma is allowed to conform
more closely to the underlying neck shape. This is the
platysma effect. Neck bands are reduced and the skin appears
smoother and firmer. Disturbing crepiness, skin bunching, and
creasing, which happen on contraction of the platysma in
middle-aged patients to older patients, are significantly re-
duced giving the appearance of a smoother and cleaner neck
skin. Patients express a feeling of desired tightness of the neck
and jawline. The Microbotox helps to tighten the skin enve-
lope through the bulk atrophy of sweat and sebaceous glands
as well by directing the force of platysma pull inward to the
cervico-mental angle.
For which concern the mid and the upper face, we need to
consider different key points. Glabellar lines, frontal lines,
crow’s feet lines, bunny lines, lower eyelid, and internal and
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external eyebrow are the traditional target points for botuli-
num toxin injections [10, 12, 13].
MBTX is injected as a complement to skin rejuvenation.
Treatment could be painful and it is more difficult to inject
precisely and to reduce pain when treating manually. In our
study, we excluded this problem using Juvapen® [8].
Despite of the treatment of the lower face and neck, where
the muscular action is more important, for mid and upper face,
the most relevant effect was the reduction of secretion of se-
baceous gland. Usually for these face areas, we used 150–180
microdroplets (Fig. 1).
Fraxel laser treatment is the universally accepted treatment
for skin pigment alterations and photoaged damaged skin.
There are studies that confirm (clinically and histologically)
the ability of Fraxel laser to induce microdamage in dermis
and in this way, it promotes the skin proliferation and rejuve-
nation. Moreover, fractional laser treatment can improve skin
texture and reduce skin wrinkles [6, 9, 14–16].
Volite is a low G prime HA. It is commonly used to aug-
ment skin texture and quality in association or not with con-
ventional Botox treatment. It has certain ability to modify skin
quality as the increase of GAG D3 and D8, collagen, fibrillin,
and AQP 3. In other words, with the injection of Volite, we
increase hydration and elasticity that allow the skin to look
brighter and softer.
On the other hand, Volite can help to reducewrinkles acting
like a common HA filler [11].
What we noticed during the study was that the skin quality
augmented more than every single treatment alone. According
to the fact that skin aging is due to multiple factors, if we act in
different ways, we can obtain better result in order to boost
skin quality and texture. As we discuss above, every single
treatment acts in a specific pattern and, if it is possible to
combine multiple techniques, skin aging could be contrasted
at 360°. The total cost for this treatment is about 3 to 4000
dollars which is distributed along 5 months, thus becoming
more affordable for the patient.
Conclusion
Skin aging is due to multifactorial agents [4]. In esthetic med-
icine, there are a lot of techniques to contrast these agents.
Usually, only one treatment is used per time but, if it is possi-
ble to act in different ways, a better skin quality and texture
could be obtained to reverse the effect of skin aging [4, 7].
In this study, we demonstrated that the usage of three treat-
ments together, like mBTX, Volite, and Fractional laser, have
a better result despite every single technique alone.
Nowadays, new technologies have allowed us to facilitate
treatments; thanks to them, the experimental studies obtain
more precise and predictable results in a shorter time [17–19].
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Fig. 1 It is useful to practice
delivering the microdroplets
consistently. Using a standard
2.5-mL dilution of 100-unit
Botox, a 0.1-mL droplet contains
4 units. A 0.05-mL droplet con-
tains 2 units. The Microbotox
droplet is very tiny as shown in
the diagram, and a 0.05-mL
droplet can further be divided into
20–30 smaller Microbotox drop-
lets each bearing a small dose of
Botox
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